おかえりなさい
Click “ログイン” to agree to Cointime’s 利用規約 and acknowledge that Cointime’s プライバシーポリシー applies to you.
アカウント登録
Already have an account?
Click “page.Sign up” to agree to Cointime’s <a class="underline" href="#term-of-service">利用規約</a> and acknowledge that Cointime’s a class="underline" href="#privacy-policy">プライバシーポリシー</a> applies to you.
siteでログインする
siteで登録する
あなたのメールアドレス
受信トレイを確認する
Click the link we sent to to sign in.
Click the link we sent to to sign up.
Orca Bio
company
About
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.
- 101 - 250
Details
- Last Funding Type
- Series D
- Last Funding Money Raised
- $192M
- Industries
- Health Care,Medical,Pharmaceutical
- Founded date
- Jan 1, 2016
- Number Of Employee
- 101 - 250
- Operating Status
- Active
Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients. Orca Bio has developed a pipeline of proprietary technologies that have the potential to impact over 100 malignant and auto-immune diseases. Orca has assembled a team of world-leading experts and technologists to execute this vision.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
1
$192M
Orca Bio has raised a total of
$192M
in funding over 2 rounds. Their latest funding was raised on
Jun 17, 2020 from a Series D round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jun 17, 2020 | Series D | $192M | 2 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
2
Orca Bio is funded by 2 investors.
Kaiser Permanente
and Dream Variation Ventures
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Kaiser Permanente
|
— | Series D |
Dream Variation Ventures
|
— | Series D |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
